C07D 277/68
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
C07D277/68 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,708 US grants and 1,288 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,708
- Published applications
- 1,288
- Assignees
- 756
- Inventors
- 4,965
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 33 | 0 |
| 1978 | 18 | 0 |
| 1979 | 10 | 0 |
| 1980 | 29 | 0 |
| 1981 | 34 | 0 |
| 1982 | 23 | 0 |
| 1983 | 29 | 0 |
| 1984 | 37 | 0 |
| 1985 | 26 | 0 |
| 1986 | 22 | 0 |
| 1987 | 22 | 0 |
| 1988 | 33 | 0 |
| 1989 | 34 | 0 |
| 1990 | 34 | 0 |
| 1991 | 35 | 0 |
| 1992 | 22 | 0 |
| 1993 | 41 | 0 |
| 1994 | 42 | 0 |
| 1995 | 32 | 0 |
| 1996 | 53 | 0 |
| 1997 | 45 | 0 |
| 1998 | 36 | 0 |
| 1999 | 35 | 0 |
| 2000 | 35 | 0 |
| 2001 | 36 | 5 |
| 2002 | 43 | 47 |
| 2003 | 36 | 71 |
| 2004 | 31 | 85 |
| 2005 | 37 | 84 |
| 2006 | 48 | 57 |
| 2007 | 43 | 64 |
| 2008 | 39 | 71 |
| 2009 | 33 | 65 |
| 2010 | 49 | 80 |
| 2011 | 56 | 54 |
| 2012 | 44 | 47 |
| 2013 | 46 | 37 |
| 2014 | 51 | 55 |
| 2015 | 40 | 45 |
| 2016 | 39 | 42 |
| 2017 | 28 | 43 |
| 2018 | 27 | 43 |
| 2019 | 31 | 45 |
| 2020 | 38 | 52 |
| 2021 | 33 | 35 |
| 2022 | 24 | 25 |
| 2023 | 18 | 41 |
| 2024 | 25 | 44 |
| 2025 | 19 | 27 |
| 2026 | 16 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds and methods of inhibiting bacterial chaperonin systems29 Sep 2026US 12,747,219 B2Arizona Board of Regents on Behalf of the University of Arizona
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Benzothiazole and quinoline derivatives and their use22 Sep 2026US 12,741,948 B2Shanghai Yao Yuan Biotechnology Co., Ltd.
- Leukotriene synthesis inhibitors21 Jul 2026US 12,686,668 B2Naegis Pharmaceuticals Inc.
- Phenethylamine derivatives, compositions, and methods of use19 May 2026US 12,630,504 B2Cybin IRL Limited
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- New antibiotic compounds3 Sep 2026US 2026/0258006 A1Centre National De La Recherche Scientifique
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
Most cited
By later US patents
- Expression of a gene for a modified green-fluorescent protein173US 5,741,668 ARutgers, The State University of New Jersey · 1998
- Novel compounds146US 5,002,953 ABeecham Group Limited · 1991
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants128US 6,720,344 B2Board of Regents, The University of Texas System · 2004
- Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity127US 4,831,031 APfizer Inc. · 1989